The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 78 (3) , 298-305
- https://doi.org/10.1016/j.radonc.2006.02.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trialThe Lancet, 2003
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35Journal of Clinical Oncology, 1999
- Overview of late effects normal tissues (LENT) scoring systemRadiotherapy and Oncology, 1995
- Late effects toxicity scoring: the SOMA scaleRadiotherapy and Oncology, 1995
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- The uniform reporting of treatment-related morbiditySeminars in Radiation Oncology, 1994
- The recording of morbidity related to radiotherapyRadiotherapy and Oncology, 1989
- Reporting results of cancer treatmentCancer, 1981
- Laryngeal Carcinoma: II. Analysis of treatment results using the Ellis modelActa Radiologica: Oncology, Radiation, Physics, Biology, 1979